Gain Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GANX and other ETFs, options, and stocks.

About GANX

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never before targeted. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. 

CEO
Matthias A. Alder
CEOMatthias A. Alder
Employees
25
Employees25
Headquarters
Bethesda, Maryland
HeadquartersBethesda, Maryland
Founded
2017
Founded2017
Employees
25
Employees25

GANX Key Statistics

Market cap
39.33M
Market cap39.33M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
29.33K
Average volume29.33K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$9.70
52 Week high$9.70
52 Week low
$2.33
52 Week low$2.33

GANX Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 11, Pre-Market
ActualExpected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.